BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35343088)

  • 21. Usefulness of roadside urine drug screening in drivers suspected of driving under the influence of drugs (DUID).
    Raes E; Verstraete AG
    J Anal Toxicol; 2005 Oct; 29(7):632-6. PubMed ID: 16419392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugged Driving in Wisconsin: Oral Fluid Versus Blood.
    Edwards LD; Smith KL; Savage T
    J Anal Toxicol; 2017 Jul; 41(6):523-529. PubMed ID: 28830121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability of roadside oral fluid testing devices for ∆
    Scherer JN; Vasconcelos M; Dalanhol CS; Govoni B; Dos Santos BP; Borges GR; de Gouveia GC; Viola PP; Carlson RLR; Martins AF; Costa JL; Huestis MA; Pechansky F
    Drug Test Anal; 2024 Mar; ():. PubMed ID: 38440942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supported liquid extraction (SLE) for the analysis of methylamphetamine, methylenedioxymethylamphetamine and delta-9-tetrahydrocannabinol in oral fluid and blood of drivers.
    Rositano J; Harpas P; Kostakis C; Scott T
    Forensic Sci Int; 2016 Aug; 265():125-30. PubMed ID: 26878366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New psychoactive substances in oral fluid of French and Belgian drivers in 2016.
    Richeval C; Wille SMR; Nachon-Phanithavong M; Samyn N; Allorge D; Gaulier JM
    Int J Drug Policy; 2018 Jul; 57():1-3. PubMed ID: 29631107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.
    Wille SM; Raes E; Lillsunde P; Gunnar T; Laloup M; Samyn N; Christophersen AS; Moeller MR; Hammer KP; Verstraete AG
    Ther Drug Monit; 2009 Aug; 31(4):511-9. PubMed ID: 19571773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence of psychoactive substances and alcohol among impaired drivers in Denmark in 2015-2019.
    Simonsen KW; Hasselstrøm JB; Hermansen SK; Rasmussen BS; Andreasen MF; Christoffersen DJ; Linnet K
    Forensic Sci Int; 2022 Apr; 333():111207. PubMed ID: 35144220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs in oral fluid in randomly selected drivers.
    Drummer OH; Gerostamoulos D; Chu M; Swann P; Boorman M; Cairns I
    Forensic Sci Int; 2007 Aug; 170(2-3):105-10. PubMed ID: 17658711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of cannabis use in drivers with the drugwipe device and by GC-MS after Intercept device collection.
    Kintz P; Bernhard W; Villain M; Gasser M; Aebi B; Cirimele V
    J Anal Toxicol; 2005 Oct; 29(7):724-7. PubMed ID: 16419408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Dräger DrugTest 5000 in a Naturalistic Setting.
    Gjerde H; Clausen GB; Andreassen E; Furuhaugen H
    J Anal Toxicol; 2018 May; 42(4):248-254. PubMed ID: 29409046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS.
    Molnar A; Fu S; Lewis J; Allsop DJ; Copeland J
    Forensic Sci Int; 2014 May; 238():113-9. PubMed ID: 24699310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Driving under the influence of cannabis: pitfalls, validation, and quality control of a UPLC-MS/MS method for the quantification of tetrahydrocannabinol in oral fluid collected with StatSure, Quantisal, or Certus collector.
    Wille SM; Di Fazio V; Ramírez-Fernandez Mdel M; Kummer N; Samyn N
    Ther Drug Monit; 2013 Feb; 35(1):101-11. PubMed ID: 23318281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical aspects of roadside tests for administrative traffic offences in Germany.
    Steinmeyer S; Ohr H; Maurer HJ; Moeller MR
    Forensic Sci Int; 2001 Sep; 121(1-2):33-6. PubMed ID: 11516885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are oral fluid testing devices effective for the roadside detection of recent cannabis use? A systematic review.
    Dobri SCD; Moslehi AH; Davies TC
    Public Health; 2019 Jun; 171():57-65. PubMed ID: 31102828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New psychoactive substances in oral fluid of drivers around a music festival in south-west France in 2017.
    Richeval C; Dumestre-Toulet V; Wiart JF; Vanhoye X; Humbert L; Nachon-Phanithavong M; Allorge D; Gaulier JM
    Forensic Sci Int; 2019 Apr; 297():265-269. PubMed ID: 30851602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for drugs of abuse in oral fluid--correlation of analysis results with serum in forensic cases.
    Toennes SW; Steinmeyer S; Maurer HJ; Moeller MR; Kauert GF
    J Anal Toxicol; 2005; 29(1):22-7. PubMed ID: 15808009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
    Biermann T; Schwarze B; Zedler B; Betz P
    Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers.
    Samyn N; De Boeck G; Verstraete AG
    J Forensic Sci; 2002 Nov; 47(6):1380-7. PubMed ID: 12455668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Illicit Drugs in Oral Fluid: Evaluation of Two Collection Devices.
    Cohier C; Mégarbane B; Roussel O
    J Anal Toxicol; 2017 Jan; 41(1):71-76. PubMed ID: 27681339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.